High-Dose Epirubicin Is Not an Alternative to Standard-Dose Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas. A Study of the EORTC Soft Tissue and Bone Sarcoma Group

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1998.735
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Low Dose-Rate Interstitial Brachytherapy in Soft Tissue Sarcomas

Sarcoma
Nuclear MedicineRadiologyImagingOncology
1999English

Treatment of Pelvic Bone and Soft Tissue Sarcoma.

Orthopedics & Traumatology
1997English

Pediatric Bone and Soft-Tissue Sarcomas

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2015English

Rapid VAC High Dose Melphalan Regimen, a Novel Chemotherapy Approach in Childhood Soft Tissue Sarcomas

British Journal of Cancer
Cancer ResearchOncology
1991English

Olaratumab and Doxorubicin for the Treatment of Metastatic Soft Tissue Sarcoma: A Retrospective Case Series

Precision and Future Medicine
2019English

Randomized Comparison of Doxorubicin Alone Versus Ifosfamide Plus Doxorubicin or Mitomycin, Doxorubicin, and Cisplatin Against Advanced Soft Tissue Sarcomas.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
1993English

Role of Trabectedin in the Treatment of Soft Tissue Sarcoma

OncoTargets and Therapy
OncologyPharmacology
2009English

Trabectedin in the Treatment of Patients With Soft Tissue Sarcoma

Nowotwory
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy